Passa al contenuto
Merck
Tutte le immagini(2)

Documenti fondamentali

845875P

Avanti

18:1 Lyso PC

Avanti Research - A Croda Brand

Sinonimo/i:

1--(9Z-octadecenoyl)-sn-glycero-3-phosphocholine; PC(18:1(9Z)/0:0); 110688

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali

Scegli un formato

25 MG
CHF 209.00
200 MG
CHF 283.00
500 MG
CHF 413.00

CHF 209.00


Check Cart for Availability

Richiedi un ordine bulk

Scegli un formato

Cambia visualizzazione
25 MG
CHF 209.00
200 MG
CHF 283.00
500 MG
CHF 413.00

About This Item

Formula empirica (notazione di Hill):
C26H52NO7P
Numero CAS:
Peso molecolare:
521.67
Numero MDL:
Codice UNSPSC:
51191904
NACRES:
NA.25

CHF 209.00


Check Cart for Availability

Richiedi un ordine bulk

Descrizione

1-oleoyl-2-hydroxy-sn-glycero-3-phosphocholine

Saggio

>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)

Stato

powder

Confezionamento

pkg of 2 × 100 mg (845875P-200mg)
pkg of 5 × 100 mg (845875P-500mg)
pkg of 1 × 25 mg (845875P-25mg)

Produttore/marchio commerciale

Avanti Research - A Croda Brand

Condizioni di spedizione

dry ice

Temperatura di conservazione

−20°C

Stringa SMILE

O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCC/C=C\CCCCCCCC)=O

InChI

1S/C26H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h12-13,25,28H,5-11,14-24H2,1-4H3/b13-12-/t25-/m1/s1
YAMUFBLWGFFICM-PTGWMXDISA-N

Descrizione generale

Lysophosphatidylcholine (LPC) is a lysophospholipid mediator.[1] This bioactive proinflammatory lipid is produced by pathological activities. It is one of the important constituent of oxidized low-density lipoprotein (Ox-LDL).[2]

Applicazioni

18:1 Lyso PC is suitable for use as a lysophospholipid mediator to compare the effect of sphingosylphosphorylcholine (SPC).[3] It has been used as a supplement in Yeast nitrogen base (YNB) medium to rescue choline auxotrophy.[4]

Azioni biochim/fisiol

Lysophosphatidylcholine (LPC) participates as a key factor in the atherogenic activity of oxidized low-density lipoprotein (Ox-LDL). It alters the roles in endothelial cells, smooth muscle cells, monocytes, macrophages, T-cells, thereby involving in atherosclerosis and inflammatory diseases. LPC activates protein kinase C, extracellular-signal-regulated kinases, protein tyrosine kinases, and Ca(2+), that are second messengers.[2]

Confezionamento

5 mL Clear Glass Sealed Ampule (845875P-200mg)
5 mL Clear Glass Sealed Ampule (845875P-25mg)
5 mL Clear Glass Sealed Ampule (845875P-500mg)

Note legali

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable


Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 10

1 of 10

18:1 Lyso PE 1-oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine, chloroform

Avanti

846725C

18:1 Lyso PE

18:0 Lyso PC 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine, chloroform

Avanti

855775C

18:0 Lyso PC

16:0 Lyso PE Avanti Research™ - A Croda Brand, powder

Avanti

856705P

16:0 Lyso PE

18:1-18:0 PC 1-oleoyl-2-stearoyl-sn-glycero-3-phosphocholine, powder

Avanti

850476P

18:1-18:0 PC

C18(Plasm) LPC 1-O-1′-(Z)-octadecenyl-2-hydroxy-sn-glycero-3-phosphocholine, powder

Avanti

852465P

C18(Plasm) LPC

14:0 Lyso PC 1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine, powder

Avanti

855575P

14:0 Lyso PC

2-18:0 Lyso PC Avanti Research™ - A Croda Brand 855774P, powder

Avanti

855774P

2-18:0 Lyso PC

18:1 Lyso PS Avanti Research™ - A Croda Brand

Avanti

858143P

18:1 Lyso PS

13:0 Lyso LPC Avanti Research™ - A Croda Brand

Avanti

LM1600

13:0 Lyso LPC

Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism
zu HDM and Jakobs KH
Biochimica et Biophysica Acta - Biomembranes, 1768(4), 923-940 (2007)
Overproduction of phospholipids by the Kennedy Pathway Leads to Hypervirulence in Candida albicans
Tams RN, et al.
Frontiers in Microbiology, 10(2), 86-86 (2019)
Regulation of ryanodine receptors by sphingosylphosphorylcholine: Involvement of both calmodulin-dependent and-independent mechanisms
Kovacs E, et al.
Biochemical and biophysical research communications, 401(2), 281-286 (2010)
Jacinto López-Sagaseta et al.
The EMBO journal, 31(8), 2047-2059 (2012-03-08)
Invariant Natural Killer T (iNKT) cells use highly restricted αβ T cell receptors (TCRs) to probe the repertoire of lipids presented by CD1d molecules. Here, we describe our studies of lysophosphatidylcholine (LPC) presentation by human CD1d and its recognition by
Sobhan Roy et al.
Proceedings of the National Academy of Sciences of the United States of America, 111(43), E4648-E4657 (2014-10-10)
CD1c is a member of the group 1 CD1 family of proteins that are specialized for lipid antigen presentation. Despite high cell surface expression of CD1c on key antigen-presenting cells and the discovery of its mycobacterial lipid antigen presentation capability

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.